{"count": 40, "results": [{"_id": "35901016", "pmid": 35901016, "pmcid": "PMC9333305", "title": "Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis", "journal": "PLoS One", "authors": ["Wang Z", "Luo J", "Zhang Y", "Xun P", "Chen Z"], "date": "2022-07-28T00:00:00Z", "doi": "10.1371/journal.pone.0271038", "meta_date_publication": "2022", "meta_volume": "17", "meta_issue": "7", "meta_pages": "e0271038", "score": 50282.605, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid carcinoma@@@ incidence and prognosis: A systematic review and meta-analysis", "citations": {"NLM": "Wang Z, Luo J, Zhang Y, Xun P, Chen Z. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis PLoS One. 2022;17(7):e0271038. PMID: 35901016", "BibTeX": "@article{35901016, title={Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis}, author={Wang Z and Luo J and Zhang Y and Xun P and Chen Z}, journal={PLoS One}, volume={17}, number={7}, pages={e0271038}}"}}, {"_id": "37773165", "pmid": 37773165, "pmcid": "PMC10542235", "title": "Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses", "journal": "Eur J Med Res", "authors": ["Li H", "Chen Y", "Hu L", "Yang W", "Gao Z", "Liu M", "Tao H", "Li J"], "date": "2023-09-29T00:00:00Z", "doi": "10.1186/s40001-023-01287-0", "meta_date_publication": "2023 Sep 29", "meta_volume": "28", "meta_issue": "1", "meta_pages": "392", "score": 50281.723, "text_hl": "Will @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use lead to a decreased risk of @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid cancer@@@? ", "citations": {"NLM": "Li H, Chen Y, Hu L, Yang W, Gao Z, Liu M, Tao H, Li J. Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses Eur J Med Res. 2023 Sep 29;28(1):392. PMID: 37773165", "BibTeX": "@article{37773165, title={Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses}, author={Li H and Chen Y and Hu L and Yang W and Gao Z and Liu M and Tao H and Li J}, journal={Eur J Med Res}, volume={28}, number={1}, pages={392}}"}}, {"_id": "35454163", "pmid": 35454163, "pmcid": "PMC9029304", "title": "Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications", "journal": "Biomolecules", "authors": ["García-Sáenz M", "Lobaton-Ginsberg M", "Ferreira-Hermosillo A"], "date": "2022-04-14T00:00:00Z", "doi": "10.3390/biom12040574", "meta_date_publication": "2022 Apr 14", "meta_volume": "12", "meta_issue": "4", "meta_pages": "", "score": 50279.844, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Differentiated @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@Thyroid Cancer@@@: Molecular Pathways and Its Clinical Implications", "citations": {"NLM": "García-Sáenz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications Biomolecules. 2022 Apr 14;12(4):. PMID: 35454163", "BibTeX": "@article{35454163, title={Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications}, author={García-Sáenz M and Lobaton-Ginsberg M and Ferreira-Hermosillo A}, journal={Biomolecules}, volume={12}, number={4}}"}}, {"_id": "37957487", "pmid": 37957487, "title": "Thyroid cancer and insulin resistance.", "journal": "Rev Endocr Metab Disord", "authors": ["Brenta G", "Di Fermo F"], "date": "2023-11-14T00:00:00Z", "doi": "10.1007/s11154-023-09849-7", "meta_date_publication": "2023 Nov 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.43, "text_hl": "The seven remaining studies on antidiabetics suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might benefit @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid cancer@@@. ", "citations": {"NLM": "Brenta G, Di Fermo F. Thyroid cancer and insulin resistance. Rev Endocr Metab Disord. 2023 Nov 14;():. PMID: 37957487", "BibTeX": "@article{37957487, title={Thyroid cancer and insulin resistance.}, author={Brenta G and Di Fermo F}, journal={Rev Endocr Metab Disord}}"}}, {"_id": "35870256", "pmid": 35870256, "title": "Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study.", "journal": "Growth Horm IGF Res", "authors": ["Sulu C", "Bektas AB", "Guzel SS", "Tay K", "Sahin S", "Durcan E", "Ozkaya HM", "Kadioglu P"], "date": "2022-06-30T00:00:00Z", "doi": "10.1016/j.ghir.2022.101484", "meta_date_publication": "2022 Jun 30", "meta_volume": "66", "meta_issue": "", "meta_pages": "101484", "score": 50259.9, "text_hl": "The risk of @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid cancer@@@ decreased with increasing duration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use. ", "citations": {"NLM": "Sulu C, Bektas AB, Guzel SS, Tay K, Sahin S, Durcan E, Ozkaya HM, Kadioglu P. Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study. Growth Horm IGF Res. 2022 Jun 30;66():101484. PMID: 35870256", "BibTeX": "@article{35870256, title={Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study.}, author={Sulu C and Bektas AB and Guzel SS and Tay K and Sahin S and Durcan E and Ozkaya HM and Kadioglu P}, journal={Growth Horm IGF Res}, volume={66}, pages={101484}}"}}, {"_id": "32021253", "pmid": 32021253, "pmcid": "PMC6954091", "title": "Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway", "journal": "Onco Targets Ther", "authors": ["He Y", "Cao L", "Wang L", "Liu L", "Huang Y", "Gong X"], "date": "2020-01-06T00:00:00Z", "doi": "10.2147/OTT.S227915", "meta_date_publication": "2020", "meta_volume": "13", "meta_issue": "", "meta_pages": "45-50", "score": 50259.508, "text_hl": "To uncover the potential effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on proliferation and apoptosis of @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid cancer@@@ @CELLLINE_CVCL:6298 @@@TPC-1@@@ cell line, and the underlying mechanism.", "citations": {"NLM": "He Y, Cao L, Wang L, Liu L, Huang Y, Gong X. Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway Onco Targets Ther. 2020;13():45-50. PMID: 32021253", "BibTeX": "@article{32021253, title={Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway}, author={He Y and Cao L and Wang L and Liu L and Huang Y and Gong X}, journal={Onco Targets Ther}, volume={13}, pages={45-50}}"}}, {"_id": "36873273", "pmid": 36873273, "pmcid": "PMC9976061", "title": "Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines", "journal": "Res Pharm Sci", "authors": ["Ghavami G", "Kiasari RE", "Pakzad F", "Sardari S"], "date": "2023-01-19T00:00:00Z", "doi": "10.4103/1735-5362.367797", "meta_date_publication": "2023 Apr", "meta_volume": "18", "meta_issue": "2", "meta_pages": "185-201", "score": 50258.72, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can target the growth of @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@TC@@@ through cellular metabolism. ", "citations": {"NLM": "Ghavami G, Kiasari RE, Pakzad F, Sardari S. Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines Res Pharm Sci. 2023 Apr;18(2):185-201. PMID: 36873273", "BibTeX": "@article{36873273, title={Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines}, author={Ghavami G and Kiasari RE and Pakzad F and Sardari S}, journal={Res Pharm Sci}, volume={18}, number={2}, pages={185-201}}"}}, {"_id": "37864896", "pmid": 37864896, "title": "Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication.", "journal": "Biomed Pharmacother", "authors": ["Ouyang J", "Feng Y", "Zhang Y", "Liu Y", "Li S", "Wang J", "Tan L", "Zou L"], "date": "2023-10-19T00:00:00Z", "doi": "10.1016/j.biopha.2023.115659", "meta_date_publication": "2023 Oct 19", "meta_volume": "168", "meta_issue": "", "meta_pages": "115659", "score": 50258.246, "text_hl": "Integration of metabolomics and transcriptomics reveals @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppresses @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@thyroid cancer@@@ progression via inhibiting glycolysis and restraining DNA replication.", "citations": {"NLM": "Ouyang J, Feng Y, Zhang Y, Liu Y, Li S, Wang J, Tan L, Zou L. Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication. Biomed Pharmacother. 2023 Oct 19;168():115659. PMID: 37864896", "BibTeX": "@article{37864896, title={Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication.}, author={Ouyang J and Feng Y and Zhang Y and Liu Y and Li S and Wang J and Tan L and Zou L}, journal={Biomed Pharmacother}, volume={168}, pages={115659}}"}}, {"_id": "32791889", "pmid": 32791889, "title": "Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.", "journal": "Thyroid", "authors": ["Shin HS", "Sun HJ", "Whang YM", "Park YJ", "Park DJ", "Cho SW"], "date": "2021-05-01T00:00:00Z", "doi": "10.1089/thy.2019.0851", "meta_date_publication": "2021 May", "meta_volume": "31", "meta_issue": "5", "meta_pages": "760-771", "score": 50256.67, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Reduces @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@Thyroid Cancer Tumor@@@ Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic @GENE_TNFSF11 @GENE_8600 @@@RANKL@@@ Productions.", "citations": {"NLM": "Shin HS, Sun HJ, Whang YM, Park YJ, Park DJ, Cho SW. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions. Thyroid. 2021 May;31(5):760-771. PMID: 32791889", "BibTeX": "@article{32791889, title={Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.}, author={Shin HS and Sun HJ and Whang YM and Park YJ and Park DJ and Cho SW}, journal={Thyroid}, volume={31}, number={5}, pages={760-771}}"}}, {"_id": "39795891", "pmid": 39795891, "title": "The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge.", "journal": "Int J Mol Sci", "authors": ["Stanciu AE", "Bolovan ML", "Zamfir-Chiru-Anton A", "Voiosu C", "Dabla PK", "Stanciu MM", "Serdarevic N", "Gherghe M"], "date": "2024-12-24T00:00:00Z", "doi": "10.3390/ijms26010037", "meta_date_publication": "2024 Dec 24", "meta_volume": "26", "meta_issue": "1", "meta_pages": "", "score": 50252.637, "text_hl": "(iii) In @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Thyroid_Neoplasms</m> @DISEASE_MESH:D013964 @@@DTC@@@/+@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppresses @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, leading to a dose-dependent reduction in @GENE_TNNI3 @GENE_7137 @@@cTn I@@@ (r = -0.59). ", "citations": {"NLM": "Stanciu AE, Bolovan ML, Zamfir-Chiru-Anton A, Voiosu C, Dabla PK, Stanciu MM, Serdarevic N, Gherghe M. The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge. Int J Mol Sci. 2024 Dec 24;26(1):. PMID: 39795891", "BibTeX": "@article{39795891, title={The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge.}, author={Stanciu AE and Bolovan ML and Zamfir-Chiru-Anton A and Voiosu C and Dabla PK and Stanciu MM and Serdarevic N and Gherghe M}, journal={Int J Mol Sci}, volume={26}, number={1}}"}}]}